Zhuo‐Xun Wu

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 19 papers. Top paper: “The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer”.

The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer

Molecular Cancer(2020)10.1186/s12943-019-1112-1

N/A

0DataRank · unranked

170 citations

Yidong Li, Qianchao Wang, Zhuo Chen, Xiaoyun Li, Zhuo‐Xun Wu +5 more

Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug Resistance

Cancers(2020)10.3390/cancers12010186

N/A

0DataRank · unranked

45 citations

Yuqi Yang, Qiu‐Xu Teng, Jing‐Quan Wang, Zi‐Ning Lei, Jing-Qiu Wang +5 more

Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro

Frontiers in Oncology(2020)10.3389/fonc.2020.00700

N/A

0DataRank · unranked

41 citations

Ning Ji, Qiu‐Xu Teng, Chao‐Yun Cai, Jing‐Quan Wang, Zhuo‐Xun Wu +5 more

Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells

Frontiers in Oncology(2020)10.3389/fonc.2020.00955

N/A

0DataRank · unranked

50 citations

Meng Zhang, Zhuo‐Xun Wu, Jing‐Quan Wang, Xing-Duo Dong, Yuqi Yang +5 more

Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor

Cancer Communications(2020)10.1002/cac2.12040

N/A

0DataRank · unranked

40 citations

Ning Ji, Chao‐Yun Cai, Jing‐Quan Wang, Zi‐Ning Lei, Qiu‐Xu Teng +5 more

Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells

International Journal of Molecular Sciences(2020)10.3390/ijms21041387

N/A

0DataRank · unranked

37 citations

Dong‐Hua Yang, Yuqi Yang, Jing‐Quan Wang, Chao‐Yun Cai, Zi‐Ning Lei +5 more

Sapitinib Reverses Anticancer Drug Resistance in Colon Cancer Cells Overexpressing the ABCB1 Transporter

Frontiers in Oncology(2020)10.3389/fonc.2020.574861

N/A

0DataRank · unranked

35 citations

Pranav Gupta, Qingbin Cui, Yunali V. Ashar, Zhuo‐Xun Wu, Leli Zeng +6 more

Reversal Effect of ALK Inhibitor NVP-TAE684 on ABCG2-Overexpressing Cancer Cells

Frontiers in Oncology(2020)10.3389/fonc.2020.00228

N/A

0DataRank · unranked

32 citations

Jing‐Quan Wang, Chao‐Yun Cai, Qingbin Cui, Yuqi Yang, Zhuo‐Xun Wu +6 more

M3814, a DNA-PK Inhibitor, Modulates ABCG2-Mediated Multidrug Resistance in Lung Cancer Cells

Frontiers in Oncology(2020)10.3389/fonc.2020.00674

N/A

0DataRank · unranked

31 citations

Peng Zheng, Yuqi Yang, Jing‐Quan Wang, Qiu‐Xu Teng, Zi‐Ning Lei +7 more

Overexpression of ABCG2 Confers Resistance to MLN7243, a Ubiquitin-Activating Enzyme (UAE) Inhibitor

Frontiers in Cell and Developmental Biology(2021)10.3389/fcell.2021.697927

N/A

0DataRank · unranked

27 citations

Yuqi Yang, Jing‐Quan Wang, Silpa Narayanan, Zi‐Ning Lei, Qiu‐Xu Teng +3 more

Overexpression of ABCC1 Confers Drug Resistance to Betulin

Frontiers in Oncology(2021)10.3389/fonc.2021.640656

N/A

0DataRank · unranked

37 citations

Yuqi Yang, Jing‐Quan Wang, Zhuo‐Xun Wu, Jing Li, Zhe‐Sheng Chen +1 more

Establishment and Characterization of an Irinotecan-Resistant Human Colon Cancer Cell Line

Frontiers in Oncology(2021)10.3389/fonc.2020.624954

N/A

0DataRank · unranked

31 citations

Yuqi Yang, Leli Zeng, Harsh Patel, Letao Bo, Lusheng Lin +2 more

The Spleen Tyrosine Kinase Inhibitor, Entospletinib (GS-9973) Restores Chemosensitivity in Lung Cancer Cells by Modulating ABCG2-mediated Multidrug Resistance

International Journal of Biological Sciences(2021)10.7150/ijbs.61229

N/A

0DataRank · unranked

10 citations

Zhuo‐Xun Wu, Jing‐Quan Wang, Hansu Ma, Nikita Acharekar, Jagadish Koya +5 more

Elevated ABCB1 Expression Confers Acquired Resistance to Aurora Kinase Inhibitor GSK-1070916 in Cancer Cells

Frontiers in Pharmacology(2021)10.3389/fphar.2020.615824

N/A

0DataRank · unranked

26 citations

Yuqi Yang, Jing‐Quan Wang, Wenmin Zhou, Junyu Chen, Yige Fu +4 more

OTS964, a TOPK Inhibitor, Is Susceptible to ABCG2-Mediated Drug Resistance

Frontiers in Pharmacology(2021)10.3389/fphar.2021.620874

N/A

0DataRank · unranked

14 citations

Zhuo‐Xun Wu, Jing‐Quan Wang, Qiu‐Xu Teng, Zi‐Ning Lei, Sabrina Lusvarghi +4 more

The Resistance of Cancer Cells to Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, is Mediated by the ABCB1 Transporter

Frontiers in Pharmacology(2022)10.3389/fphar.2022.861642

N/A

0DataRank · unranked

19 citations

Zhuo‐Xun Wu, Zi‐Ning Lei, Qiu‐Xu Teng, Yuqi Yang, Charles R. Ashby +4 more

PBK/TOPK inhibitor OTS964 resistance is mediated by ABCB1-dependent transport function in cancer: in vitro and in vivo study

Molecular Cancer(2022)10.1186/s12943-022-01512-0

N/A

0DataRank · unranked

14 citations

Qiu‐Xu Teng, Zhuo‐Xun Wu, Jing‐Quan Wang, Zi‐Ning Lei, Sabrina Lusvarghi +4 more

ABCB1 limits the cytotoxic activity of TAK-243, an inhibitor of the ubiquitin-activating enzyme UBA1

Frontiers in Bioscience-Landmark(2022)10.31083/j.fbl2701005

N/A

0DataRank · unranked

9 citations

Yuqi Yang, Zi‐Ning Lei, Silpa Narayanan, Jing‐Quan Wang, Qiu‐Xu Teng +5 more

Design, synthesis, and biological evaluation of phenylurea indole derivatives as ABCG2 inhibitors

Bioorganic Chemistry(2023)10.1016/j.bioorg.2023.106481

N/A

0DataRank · unranked

8 citations

Chao‐Yun Cai, Xing-Duo Dong, Zhuo‐Xun Wu, Qiu‐Xu Teng, Jing‐Quan Wang +3 more